Kratom as a popular product for self-treatment: An overview for pharmacists

Decorative course banner image

Program Details

  • Intended Audience:  This program is intended for pharmacists interested in kratom properties and care recommendations.
  • Universal Activity Number: 0012-0000-24-021-H01-P
  • Contact Hours: 4.0 Consultant Recertification/General hours of ACPE continuing education for pharmacists
  • Program Fees: 
    • Regular Registration: $65.00
    • UF Preceptor/Career Coach: $55.00
    • UF COP Faculty: $45.00
  • UAN Release Date: 09/12/2024
  • UAN Expiration Date: 09/12/2027
  • Activity Type: Application
  • Program Support: No outside financial support was provided.
  • Format Type: This course is self-paced, fully online.
  • Time to Complete: All coursework must be completed within 24 weeks from the date of registration or before date of UAN expiration, 09/12/2027, whichever comes first. This course will no longer be eligible for CE credit after 09/12/2027.

Summary

Over the past decade, products derived from the leaves of the Kratom (Mitragyna speciosa) tree have gained popularity in the US. The leaf preparations, native to countries in Southeast Asia, are estimated to be used by 2-15 million users in the US alone, often in combination with other supplements, over the counter and prescription drugs (Henningfield et al., 2022). Kratom products are reported to be used for a range of self-treatment options including pain, mental disorders, mitigation of drug withdrawal symptoms, and mood elevation in general (Swogger et al. 2022). Most clinical practitioners, including pharmacists, are not knowledgeable about kratom products and not well equipped to counsel patients.

To address this deficiency, the “Kratom as a popular product for self-treatment: An overview for pharmacists” course will provide practicing pharmacists with an overview of kratom’s known pharmacology, chemistry, pharmacokinetics, and use patterns. This includes potential pharmacokinetic and pharmacodynamic drug interactions and current patterns of use and related pharmacological evidence to support such uses. In addition, kratom products vary in composition including raw leaf material, hydroalcoholic extracts, and isolated compounds and the course will provide participants with an understanding of differences between such products.

Given that a majority of kratom users do report pre-existing conditions and, in many cases, receive pharmacotherapy, the course will emphasize the counseling points to benefit patient care.

This course is approved by the Florida Board of Pharmacy for 4.0 contact hours to meet requirements pursuant to CHAPTER 64B16-26, Florida Statutes and Rule 64B16-26.300, Florida Administrative Code.


Objectives

At the completion of this activity, the participant will be able to:

  1. Describe the diverse pharmacology of kratom and its proposed active components.
  2. Assess available kratom products based on their label regarding quality and potential for drug interactions.
  3. Evaluate and recommend appropriate use of kratom to different patient populations.
  4. Identify the self-treatment uses of kratom and limitations of use.

Requirements for Successful Course Completion

In order to earn credit for this course, participants must pass a final assessment with a score of 70% or higher. Two chances to pass the final assessment will be given. If a passing score is not earned by the second attempt, the participant must re-enroll in the course. Upon successful completion of all coursework, participants must complete a course evaluation form.


Course Access

To access your course after enrollment, please click the link below.

http://elearning.ufl.edu/

Click the blue “Log in to Continuing Education” button and enter your login credentials. You should then see your course on the Canvas dashboard or by clicking Courses>All Courses.


Disclosure Statement

Oliver Grundmann Ph.D. (Planning Committee, Reviewer, Faculty) has disclosed that he is performing an expert report on the toxicity of kratom for Kava Co, LLC. All relevant financial relationships for Dr. Grundmann have been mitigated. No other faculty, planners, or others in a position to control content have any financial relationships with ineligible companies to disclose.

  • Teresa E Roane Pharm.D., MBA, BCACP (Planning Committee)
  • Emely McKitrick (Planning Committee)
  • Aubrey Carey (Planning Committee)
  • Nacacia Robinson (Planning Committee)
  • Rachel Shaddock Pharm.D. (Reviewer, Author)
  • Christopher R McCurdy Ph.D., F.A.A.P.S. (Faculty)
  • Abhisheak Sharma M.Pharm., Ph.D. (Faculty)
  • Jay McLaughlin Ph.D. (Faculty)
  • Alicia Tudor M.D. (Faculty)

Visit https://cpe.pharmacy.ufl.edu/coi-resources/ for more information on management of conflicts of interest.


  • J.E. Henningfield, O. Grundmann, A. Garcia-Romeu, M.T. Swogger, We Need Better Estimates of Kratom Use Prevalence, American Journal of Preventive Medicine. 2022; 62(1):132-133.
  • M.T. Swogger, K.E. Smith, A. Garcia-Romeu, O. Grundmann, C.A. Veltri, J.E. Henningfield, L.Y. Busch, Understanding Kratom Use: A Guide for Healthcare Providers, Frontiers in Pharmacology. 2022; 13:801855.

Additional Resources

Please review the resources below before registering for the course.


ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.